These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

734 related articles for article (PubMed ID: 15510160)

  • 21. Analysing p53 tumour suppressor functions in mice.
    Sluss HK; Jones SN
    Expert Opin Ther Targets; 2003 Feb; 7(1):89-99. PubMed ID: 12556205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
    Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
    J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis.
    D'Orazi G; Cecchinelli B; Bruno T; Manni I; Higashimoto Y; Saito S; Gostissa M; Coen S; Marchetti A; Del Sal G; Piaggio G; Fanciulli M; Appella E; Soddu S
    Nat Cell Biol; 2002 Jan; 4(1):11-9. PubMed ID: 11780126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of p53 function.
    Woods DB; Vousden KH
    Exp Cell Res; 2001 Mar; 264(1):56-66. PubMed ID: 11237523
    [No Abstract]   [Full Text] [Related]  

  • 25. Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate.
    Knights CD; Catania J; Di Giovanni S; Muratoglu S; Perez R; Swartzbeck A; Quong AA; Zhang X; Beerman T; Pestell RG; Avantaggiati ML
    J Cell Biol; 2006 May; 173(4):533-44. PubMed ID: 16717128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of p53 activity in nuclear bodies by a specific PML isoform.
    Fogal V; Gostissa M; Sandy P; Zacchi P; Sternsdorf T; Jensen K; Pandolfi PP; Will H; Schneider C; Del Sal G
    EMBO J; 2000 Nov; 19(22):6185-95. PubMed ID: 11080164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The HAUSP gene plays an important role in non-small cell lung carcinogenesis through p53-dependent pathways.
    Masuya D; Huang C; Liu D; Nakashima T; Yokomise H; Ueno M; Nakashima N; Sumitomo S
    J Pathol; 2006 Apr; 208(5):724-32. PubMed ID: 16450335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redox modulation of p53: mechanisms and functional significance.
    Kim DH; Kundu JK; Surh YJ
    Mol Carcinog; 2011 Apr; 50(4):222-34. PubMed ID: 21465572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.
    Ito A; Lai CH; Zhao X; Saito S; Hamilton MH; Appella E; Yao TP
    EMBO J; 2001 Mar; 20(6):1331-40. PubMed ID: 11250899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes.
    Scian MJ; Stagliano KE; Deb D; Ellis MA; Carchman EH; Das A; Valerie K; Deb SP; Deb S
    Oncogene; 2004 May; 23(25):4430-43. PubMed ID: 15077194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
    Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
    Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Massively regulated genes: the example of TP53.
    Hollstein M; Hainaut P
    J Pathol; 2010 Jan; 220(2):164-73. PubMed ID: 19918835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
    Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
    Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.
    Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I
    Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1.
    Vega FM; Sevilla A; Lazo PA
    Mol Cell Biol; 2004 Dec; 24(23):10366-80. PubMed ID: 15542844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.
    Komura N; Asakawa M; Umezawa K; Segawa K
    Exp Cell Res; 2007 Aug; 313(13):2753-65. PubMed ID: 17585903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockage of CRM1-dependent nuclear export of the adenovirus type 5 early region 1B 55-kDa protein augments oncogenic transformation of primary rat cells.
    Endter C; Härtl B; Spruss T; Hauber J; Dobner T
    Oncogene; 2005 Jan; 24(1):55-64. PubMed ID: 15480414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTEN: a default gate-keeping tumor suppressor with a versatile tail.
    Wang X; Jiang X
    Cell Res; 2008 Aug; 18(8):807-16. PubMed ID: 18626510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-translational modifications and activation of p53 by genotoxic stresses.
    Appella E; Anderson CW
    Eur J Biochem; 2001 May; 268(10):2764-72. PubMed ID: 11358490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [p53 activation by PI-3K family kinases after DNA double-strand breaks].
    Pernin D; Uhrhammer N; Verrelle P; Bignon YJ; Bay JO
    Bull Cancer; 2000 Sep; 87(9):635-41. PubMed ID: 11038413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.